{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T02:14:24Z","timestamp":1775009664385,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100010438","name":"Poznan University of Medical Sciences","doi-asserted-by":"crossref","award":["502-14-01127189-08576"],"award-info":[{"award-number":["502-14-01127189-08576"]}],"id":[{"id":"10.13039\/501100010438","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.humimm.2017.06.002","type":"journal-article","created":{"date-parts":[[2017,6,10]],"date-time":"2017-06-10T10:30:37Z","timestamp":1497090637000},"page":"559-564","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Serum alarm antiproteases in systemic sclerosis patients"],"prefix":"10.1016","volume":"78","author":[{"given":"Anna","family":"Olewicz-Gawlik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota","family":"Trzybulska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Graniczna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Kuznar-Kaminska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Katulska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halina","family":"Batura-Gabryel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Frydrychowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Danczak-Pazdrowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iwona","family":"Mozer-Lisewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2017.06.002_b0005","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1146\/annurev.iy.12.040194.005015","article-title":"Tolerance, danger, and the extended family","volume":"12","author":"Matzinger","year":"1994","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.humimm.2017.06.002_b0010","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/rr18","article-title":"The role of secretory leukocyte proteinase inhibitor and elafin (elastase-specific inhibitor\/skin-derived antileukoprotease) as alarm antiproteinases in inflammatory lung disease","volume":"1","author":"Sallenave","year":"2000","journal-title":"Respir. Res."},{"key":"10.1016\/j.humimm.2017.06.002_b0015","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1042\/CS20050115","article-title":"SLPI and elafin: one glove, many fingers","volume":"110","author":"Williams","year":"2006","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.humimm.2017.06.002_b0020","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1172\/JCI118056","article-title":"Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro","volume":"96","author":"McNeely","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.humimm.2017.06.002_b0025","doi-asserted-by":"crossref","first-page":"7526","DOI":"10.1128\/JVI.02243-12","article-title":"Antiviral activity of trappin-2 and elafin in vitro and in vivo against genital herpes","volume":"87","author":"Drannik","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.humimm.2017.06.002_b0030","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1073\/pnas.83.18.6692","article-title":"Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase","volume":"83","author":"Thompson","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.humimm.2017.06.002_b0035","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1128\/IAI.73.3.1271-1274.2005","article-title":"Anti-inflammatory and antimicrobial roles of secretory leukocyte protease inhibitor","volume":"73","author":"Doumas","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.humimm.2017.06.002_b0040","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1165\/ajrcmb\/8.4.439","article-title":"Characterization and gene sequence of the precursor of elafin, an elastase-specific inhibitor in bronchial secretions","volume":"8","author":"Sallenave","year":"1993","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.humimm.2017.06.002_b0045","doi-asserted-by":"crossref","first-page":"12028","DOI":"10.1016\/S0021-9258(19)50303-9","article-title":"SKALP\/elafin: an elastase inhibitor from cultured human keratinocytes. Purification, cDNA sequence, and evidence for transglutaminase cross-linking","volume":"268","author":"Molhuizen","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.humimm.2017.06.002_b0050","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1042\/BST0391437","article-title":"SLPI and elafin: multifunctional antiproteases of the WFDC family","volume":"39","author":"Scott","year":"2011","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.humimm.2017.06.002_b0055","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3109\/s10165-011-0553-1","article-title":"Clinical significance of serum levels of secretory leukocyte protease inhibitor in patients with systemic sclerosis","volume":"22","author":"Aozasa","year":"2012","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.humimm.2017.06.002_b0060","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000406","article-title":"Elafin is a biomarker of graft-versus-host disease of the skin","volume":"2","author":"Paczesny","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.humimm.2017.06.002_b0065","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/039463201002300139","article-title":"Clinical, serologic and instrumental data of ten patients affected by sclerodermatous chronic graft versus host disease: similarities and differences in respect to systemic sclerosis","volume":"23","author":"Barausse","year":"2010","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.humimm.2017.06.002_b0070","first-page":"1468","article-title":"Autoantibodies to bactericidal\/permeability-increasing protein and cathepsin G in systemic sclerosis","volume":"31","author":"Grypiotis","year":"2004","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.humimm.2017.06.002_b0075","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1297-319X(02)00367-6","article-title":"Antineutrophil cytoplasmic antibodies in scleroderma patients: first report of a case with anti-proteinase 3 antibodies and review of the literature","volume":"69","author":"Caramaschi","year":"2002","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.humimm.2017.06.002_b0080","first-page":"228","article-title":"From a neutrophilic synovial tissue infiltrate to a challenging case of rheumatoid arthritis","volume":"35","author":"Mour\u00e3o","year":"2010","journal-title":"Acta Reumatol. Port."},{"key":"10.1016\/j.humimm.2017.06.002_b0085","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1124\/pr.110.002733","article-title":"Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases","volume":"62","author":"Korkmaz","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.humimm.2017.06.002_b0090","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.biochi.2007.10.009","article-title":"Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physiopathological functions","volume":"90","author":"Korkmaz","year":"2008","journal-title":"Biochimie"},{"key":"10.1016\/j.humimm.2017.06.002_b0095","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma)","volume":"23","author":"Masi","year":"1980","journal-title":"Arthritis Rheum."},{"issue":"2013","key":"10.1016\/j.humimm.2017.06.002_b0100","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"Classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"2010","key":"10.1016\/j.humimm.2017.06.002_b0105","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.humimm.2017.06.002_b0110","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.humimm.2017.06.002_b0115","first-page":"1281","article-title":"Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis","volume":"22","author":"Clements","year":"1995","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.humimm.2017.06.002_b0120","first-page":"S5","article-title":"Assessment of skin, joint, tendon and muscle involvement","volume":"21","author":"Akesson","year":"2003","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.humimm.2017.06.002_b0125","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1136\/ard.62.9.901","article-title":"European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria","volume":"62","author":"Valentini","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.humimm.2017.06.002_b0130","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.humimm.2017.06.002_b0135","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0950-3579(87)80030-4","article-title":"The measurement of pain","volume":"1","author":"Bird","year":"1987","journal-title":"Baillieres Clin. Rheumatol."},{"key":"10.1016\/j.humimm.2017.06.002_b0140","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1164\/rccm.200804-615OC","article-title":"Secretory leukocyte protease inhibitor: a secreted pattern recognition receptor for mycobacteria","volume":"179","author":"Gomez","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.humimm.2017.06.002_b0145","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0896-8411(92)90004-A","article-title":"Antibodies to mycobacterial 65kDa heat shock protein in systemic sclerosis (scleroderma)","volume":"5","author":"Danieli","year":"1992","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.humimm.2017.06.002_b0150","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1165\/ajrcmb.11.6.7946401","article-title":"Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI\/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes","volume":"11","author":"Sallenave","year":"1994","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.humimm.2017.06.002_b0155","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3899\/jrheum.080269","article-title":"Elevated serum concentrations of polymorphonuclear neutrophilic leukocyte elastase in systemic sclerosis: association with pulmonary fibrosis","volume":"36","author":"Hara","year":"2009","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.humimm.2017.06.002_b0160","first-page":"359","article-title":"Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase","volume":"48","author":"van Wetering","year":"2000","journal-title":"J. Investig. Med."},{"key":"10.1016\/j.humimm.2017.06.002_b0165","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1046\/j.1365-2133.2000.03766.x","article-title":"Elafin is induced in epidermis in skin disorders with dermal neutrophilic infiltration: interleukin-1 beta and tumour necrosis factor-alpha stimulate its secretion in vitro","volume":"143","author":"Tanaka","year":"2000","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.humimm.2017.06.002_b0170","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.4049\/jimmunol.145.12.4154","article-title":"Analysis of IL-1 and TNF-alpha gene expression in human rheumatoid synoviocytes and normal monocytes by in situ hybridization","volume":"145","author":"MacNaul","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2017.06.002_b0175","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/rheumatology\/ker123","article-title":"Relative \u03b11-anti-trypsin deficiency in systemic sclerosis","volume":"50","author":"Barnes","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.humimm.2017.06.002_b0180","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s004030050475","article-title":"TNF-alpha and serum induce SKALP\/elafin gene expression in human keratinocytes by a p38 MAP kinase-dependent pathway","volume":"292","author":"Pfundt","year":"2000","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.humimm.2017.06.002_b0185","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cellimm.2014.08.009","article-title":"Quantitative analysis of elastase and cathepsin G mRNA levels in peripheral blood CD14(+) cells from patients with rheumatoid arthritis","volume":"292","author":"Trzybulska","year":"2014","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.humimm.2017.06.002_b0190","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0014-5793(99)01004-2","article-title":"Human neutrophil elastase regulates the expression and secretion of elafin (elastase-specific inhibitor) in type II alveolar epithelial cells","volume":"457","author":"Reid","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.humimm.2017.06.002_b0195","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1165\/rcmb.2005-0405OC","article-title":"The antimicrobial\/elastase inhibitor elafin regulates lung dendritic cells and adaptive immunity","volume":"34","author":"Roghanian","year":"2006","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.humimm.2017.06.002_b0200","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1046\/j.1365-2249.2003.02024.x","article-title":"Increased expression of the secretory leukocyte proteinase inhibitor in Wegener's granulomatosis","volume":"131","author":"Ohlsson","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.humimm.2017.06.002_b0205","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1182\/blood-2013-06-508887","article-title":"A lack of secretory leukocyte protease inhibitor (SLPI) causes defects in granulocytic differentiation","volume":"123","author":"Klimenkova","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2017.06.002_b0210","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/0-306-46826-3_43","article-title":"Inactivation of interleukin-6 by neutrophil proteases at sites of inflammation. Protective effects of soluble IL-6 receptor chains","volume":"477","author":"Bank","year":"2000","journal-title":"Adv. Exp. Med. Biol."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885917300915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885917300915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:18:04Z","timestamp":1692836284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885917300915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0198885917300915"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2017.06.002","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum alarm antiproteases in systemic sclerosis patients","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2017.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc. on behalf of American Society for Histocompatibility and Immunogenetics.","name":"copyright","label":"Copyright"}]}}